Correlation Between Regeneron Pharmaceuticals and Novo Nordisk

Can any of the company-specific risk be diversified away by investing in both Regeneron Pharmaceuticals and Novo Nordisk at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regeneron Pharmaceuticals and Novo Nordisk into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Regeneron Pharmaceuticals and Novo Nordisk AS, you can compare the effects of market volatilities on Regeneron Pharmaceuticals and Novo Nordisk and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regeneron Pharmaceuticals with a short position of Novo Nordisk. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regeneron Pharmaceuticals and Novo Nordisk.

Diversification Opportunities for Regeneron Pharmaceuticals and Novo Nordisk

0.58

Correlation Coefficient

Regeneron Pharmaceuticals  Novo Nordisk

Very weak diversification

The 3 months correlation between Regeneron and Novo is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Regeneron Pharmaceuticals and Novo Nordisk AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novo Nordisk AS and Regeneron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regeneron Pharmaceuticals are associated (or correlated) with Novo Nordisk. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novo Nordisk AS has no effect on the direction of Regeneron Pharmaceuticals i.e., Regeneron Pharmaceuticals and Novo Nordisk go up and down completely randomly.

Pair Corralation between Regeneron Pharmaceuticals and Novo Nordisk

Given the investment horizon of 90 days Regeneron Pharmaceuticals is expected to generate 0.72 times more return on investment than Novo Nordisk. However, Regeneron Pharmaceuticals is 1.38 times less risky than Novo Nordisk. It trades about -0.07 of its potential returns per unit of risk. Novo Nordisk AS is currently generating about -0.11 per unit of risk. If you would invest  70,169  in Regeneron Pharmaceuticals on December 28, 2024 and sell it today you would lose (6,433) from holding Regeneron Pharmaceuticals or give up 9.17% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Regeneron Pharmaceuticals  vs.  Novo Nordisk AS

Regeneron Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Regeneron Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's technical and fundamental indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Novo Nordisk AS

Risk-Adjusted Performance

Very Weak

Over the last 90 days Novo Nordisk AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Regeneron Pharmaceuticals and Novo Nordisk

The main advantage of trading using opposite Regeneron Pharmaceuticals and Novo Nordisk positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regeneron Pharmaceuticals position performs unexpectedly, Novo Nordisk can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novo Nordisk will offset losses from the drop in Novo Nordisk's long position.

The idea behind Regeneron Pharmaceuticals and Novo Nordisk AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.